HIV
Conference Coverage
Extreme alcohol use worsens HIV disease
Durban, South Africa – In HIV-infected U.S. military veterans, only the highest level of persistent heavy drinking is associated with more...
Conference Coverage
Antiretroviral efavirenz linked to increased suicidality
DURBAN, SOUTH AFRICA – Screen for depression and other psychiatric disorders before placing an HIV-positive patient on efavirenz.
Conference Coverage
Intensified rifampicin boosts outcomes in TB/HIV coinfection
DURBAN, SOUTH AFRICA – High-dose rifampicin improves survival in patients who are coinfected with tuberculosis and HIV and have low CD4 counts.
Conference Coverage
HIV-related lymphoma rate remains sky-high despite ART
DURBAN, SOUTH AFRICA – Antiretroviral therapy has had a major impact upon the incidence of HIV-related non-Hodgkin lymphoma but not Hodgkin...
Conference Coverage
Monitoring renal function during daily oral HIV PrEP
Key clinical point: Monitoring creatinine clearance every 6 months is optimal in patients taking tenofovir/emtricitabine for pre-exposure...
News
Don’t delay treatment for patients with TB and HIV
Clinicians should treat patients diagnosed with HIV and tuberculosis for both conditions immediately, according to new guidelines on the treatment...
Conference Coverage
CMV viremia not culprit in high mortality of TB/HIV coinfection
DURBAN, SOUTH AFRICA – Cytomegalovirus viremia is common in patients hospitalized for HIV-associated tuberculosis, but treating the CMV infection...
News
Changes in HIV-related cancers reflect changes in HIV patient care
Key clinical point: Kaposi’s sarcoma and non-Hodgkin lymphoma are appearing in older, less- immunosuppressed patients. Major finding: From 1996-...
Conference Coverage
HIV chemoprophylaxis shown effective in 15-year-olds
DURBAN, SOUTH AFRICA – The licensed indication for daily emtricitabine/tenofovir for prevention of HIV infection could be expanded to include high...
Conference Coverage
HIV chemoprophylaxis in U.S. up 738% in recent 3-year period
DURBAN, SOUTH AFRICA – More than 79,000 Americans started taking emtricitabine/tenofovir for prevention of HIV infection during a recent 3-year...
Conference Coverage
Starting antiretroviral therapy on same day as HIV testing improves outcomes
DURBAN, SOUTH AFRICA – Starting antiretroviral therapy on the same day a patient undergoes HIV testing is clinically advantageous.